Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tivic Health Systems ( (TIVC) ) has provided an announcement.
On March 13, 2026, Velocity Bioworks entered into an eight-year lease for an approximately 8,024-square-foot microbial facility in San Antonio, with a one-time five-year extension option and an exclusive right to buy the building and property within the first 24 months for $12.5 million. The deal commits the company to roughly $5.34 million in base rent over the term, plus operating, tax, and utility expenses, signaling a long-term investment in microbial production capacity.
On March 9, 2026, VBI also signed a 102-month lease effective January 1, 2026, for a 20,144-square-foot mammalian facility at the same property, with aggregate base rent of about $6.29 million and similar pass-through costs, expanding its mammalian operations footprint. In a parallel move on March 13, 2026, VBI subleased 8,122 square feet of office space at the site to serve as Tivic Health’s new principal executive office, indicating a strategic consolidation of R&D, manufacturing, and corporate headquarters at a single San Antonio campus to support future growth and operational efficiency.
The most recent analyst rating on (TIVC) stock is a Hold with a $0.98 price target. To see the full list of analyst forecasts on Tivic Health Systems stock, see the TIVC Stock Forecast page.
Spark’s Take on TIVC Stock
According to Spark, TipRanks’ AI Analyst, TIVC is a Neutral.
The score is primarily held down by weak financial performance (minimal revenue, persistent losses, and significant cash burn). Technicals also remain bearish with the stock below major moving averages and negative MACD. Strategic progress and improved cash on the earnings update provide partial support, but financing-related leverage/dilution risk and a negative earnings-based valuation keep the overall score low.
To see Spark’s full report on TIVC stock, click here.
More about Tivic Health Systems
Tivic Health Systems, through its wholly owned subsidiary Velocity Bioworks, operates in the life sciences and biotechnology sector, focusing on microbial and mammalian bioworks capabilities and related office-based corporate functions. The company is consolidating operations at a multi-building property in San Antonio, Texas, which will now include laboratory, manufacturing, and its new principal executive offices.
Average Trading Volume: 1,060,349
Technical Sentiment Signal: Sell
Current Market Cap: $2.33M
See more insights into TIVC stock on TipRanks’ Stock Analysis page.